Safety profile of bevacizumab on cultured human corneal cells.
about
Substrates for Expansion of Corneal Endothelial Cells towards Bioengineering of Human Corneal EndotheliumThe effect of bevacizumab on corneal neovascularization in rabbits.Corneal neovascularization: an anti-VEGF therapy review.Recent advances in the management of neovascular glaucoma.Cytotoxic properties of sunitinib and sorafenib on human corneal epithelial cells.Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumabEffect of Bevacizumab on Human Tenon's Fibroblasts Cultured from Primary and Recurrent PterygiumSafety of bevacizumab on extraocular muscle in a rabbit model.Corneal transparency: genesis, maintenance and dysfunctionCurrent Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.Recent drug therapies for corneal neovascularization.Bevacizumab can induce reactivity to VEGF-C and -D in human brain and tumour derived endothelial cells.Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats.Anti-angiogenic therapy (bevacizumab) in the management of oral lichen planus.Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cellsTopical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model.Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucomaChemical injury treated with autologous limbal epithelial stem cell transplantation and subconjunctival bevacizumab.Evaluating the safety of intracameral bevacizumab application using oxidative stress and apoptotic parameters in corneal tissue.Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma.Corneal endothelial safety following subconjunctival and intrastromal injection of bevacizumab for corneal neovascularization.The effect and safety of intravitreal injection of ranibizumab and bevacizumab on the corneal endothelium in the treatment of diabetic macular edema.Safety of antivascular endothelial growth factor administration in the ocular anterior segment in pterygium and neovascular glaucoma treatment: Systematic review and meta-analysis
P2860
Q26785894-DC98D18A-E5ED-48A2-B8DD-90697D24E94FQ34044322-CEE27E9B-BAE5-49ED-9E1E-E55F61A7D340Q34641522-A7BC4D49-B96B-4589-8953-E83B973A91C7Q34734475-85873B5B-9FE0-47A0-A5FE-08C4C1F83DB8Q35001062-02F6E65C-F70E-4165-B31B-0329F1AFDD78Q35226694-757556CB-3BAC-4195-B9BB-550EA8A6D34DQ35843974-B2926A53-559F-4F39-AB07-E0866413D909Q36128246-F8A0C729-AAD6-42B2-B169-1E7926C452D0Q37500924-AAAD3934-86D8-4E92-AFE7-E53FFF81CB3CQ37672460-5C1E9D04-58D6-44CE-9E52-D8DC226AAA6DQ39295602-DFE305AA-1E9E-4F71-BFAD-E638AD530136Q39595054-BC5D2B6A-B5DB-4476-B962-57F01773BD7FQ39965612-12DCB024-A710-4E01-865F-B58AD693B0EEQ39986140-C646F550-1710-4634-8D2F-0CC2D3D73774Q40018607-AFA3B60A-DE4D-42A8-8793-C052411D0CC5Q40032771-53D082AB-3443-4C2C-89AC-A49A08F99812Q41891488-767A59C6-1221-4F53-8AFE-4AB6666D0314Q42114007-66EBE32B-FF00-48B8-9BC6-C553712FD137Q42567095-D19ACD80-3796-49BC-8B1C-3FC599BFD9A2Q42789148-408AFAF7-F151-41FE-BF05-F44446067789Q45359325-ECF3CF9F-7370-4A7E-91B5-4D52700DB2C8Q53165663-F8920326-370E-45BA-BE32-DF6F33D05D5FQ58706505-1DA43327-D8D0-4B4D-8D07-050925729BE0
P2860
Safety profile of bevacizumab on cultured human corneal cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Safety profile of bevacizumab on cultured human corneal cells.
@ast
Safety profile of bevacizumab on cultured human corneal cells.
@en
Safety profile of bevacizumab on cultured human corneal cells.
@nl
type
label
Safety profile of bevacizumab on cultured human corneal cells.
@ast
Safety profile of bevacizumab on cultured human corneal cells.
@en
Safety profile of bevacizumab on cultured human corneal cells.
@nl
prefLabel
Safety profile of bevacizumab on cultured human corneal cells.
@ast
Safety profile of bevacizumab on cultured human corneal cells.
@en
Safety profile of bevacizumab on cultured human corneal cells.
@nl
P2093
P1433
P1476
Safety profile of bevacizumab on cultured human corneal cells.
@en
P2093
Efdal Yoeruek
Martin S Spitzer
Olcay Tatar
Peter Szurman
P304
P356
10.1097/ICO.0B013E3180DE1D0A
P577
2007-09-01T00:00:00Z